VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
11,636
+2,974
+34% +$584K 0.62% 44
2026
Q1
$1.7M Sell
8,662
-761
-8% -$148K 0.47% 44
2025
Q4
$1.64M Buy
+9,423
New +$1.72M 0.45% 55

Other funds holding DGX

VCI Wealth Management's DGX Position: Q2 2026 in Review

VCI Wealth Management increased its Quest Diagnostics (DGX) stake by 34% in Q2 2026, buying an estimated $584K and bringing the position to 11,636 shares worth $2.47M. The position accounts for 0.62% of the portfolio, ranked #44.

VCI Wealth Management first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • VCI Wealth Management held 11,636 shares of Quest Diagnostics worth $2.47M as of Q2 2026.
  • VCI Wealth Management bought 2,974 Quest Diagnostics shares in Q2 2026, an estimated $584K.
  • Quest Diagnostics made up 0.62% of VCI Wealth Management's portfolio in Q2 2026, its #44 holding.
  • VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on VCI Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.